Testosterone therapy in men with prostate cancer

AL Kaplan, JC Hu, A Morgentaler, JP Mulhall… - European urology, 2016 - Elsevier
Context The use of testosterone therapy in men with prostate cancer was previously
contraindicated, although recent data challenge this axiom. Over the past 2 decades, there …

Repeat prostate biopsy: who, how and when?: a review

B Djavan, M Remzi, CC Schulman, M Marberger… - European urology, 2002 - Elsevier
Urologists are frequently faced with the dilemma of treating a patient with a high index of
suspicion of prostate cancer (PCa), but an initial set of negative biopsies. In this review, we …

The interpretation of serum prostate specific antigen in men receiving 5α-reductase inhibitors: a review and clinical recommendations

LS Marks, GL Andriole, JM Fitzpatrick… - The Journal of …, 2006 - Elsevier
PURPOSE: We reviewed the effects of 5α-reductase inhibitors on prostate specific antigen
and clarified the adjustments that should be made to compensate for these effects to ensure …

Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?

BOB Djavan, V Ravery, A Zlotta, P Dobronski… - The Journal of …, 2001 - auajournals.org
Purpose: We evaluated biochemical parameters and pathological features, as well as
biopsy related morbidity of prostate cancer detected on biopsies 2, 3 and 4 in men with total …

Radiofrequency Interstitial Tumor Ablation (RITA) Is a Possible New Modality for Treatment of Renal Cancer: Ex Vivo and in Vivo Experience

AR ZLOTTA, T Wildschutz, G Raviv, MO Peny… - Journal of …, 1997 - liebertpub.com
Small renal tumors are increasingly diagnosed and are frequently treated by nephron-
sparing surgery. Tumors can be ablated by radiofrequency (RF) energy, which allows the …

[PDF][PDF] Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder?

P Montorsi, F Montorsi, CC Schulman - European urology, 2003 - academia.edu
Erectile function is a psychoneurovascular phenomenon which ultimately culminates in an
increase of arterial flow within the hypogastric-penile bed with the subsequent activation of …

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men

BOB Djavan, A Zlotta, M Remzi, K Ghawidel… - The Journal of …, 2000 - auajournals.org
Purpose: We compare the ability of total prostate specific antigen (PSA), percent free PSA,
PSA density and transition zone PSA density to predict the outcome of repeat prostatic …

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo …

MA Carducci, RJ Padley, J Breul… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To evaluate the efficacy and safety of atrasentan (ABT-627), an endothelin-A
receptor antagonist, in the treatment of asymptomatic, hormone-refractory prostatic …

Extraperitoneal laparoscopic radical prostatectomy: results after 50 cases

R Bollens, M Vanden Bossche, T Roumeguere… - European …, 2001 - karger.com
Introduction: After an initial experience using transperitoneal laparoscopic radical
prostatectomy as described by Vallancien and Guillonneau, we developed a pure …

4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate …

CC Schulman, FMJ Debruyne, G Forster… - European …, 2000 - karger.com
Objectives: To evaluate the long–term effects of 3–month neoadjuvant hormonal treatment in
patients treated by radical prostatectomy for locally confined prostate cancer. Methods: We …